$14.10
2.78%
Nasdaq, Nov 09, 03:04 pm EST. Market open.
ISIN
IL0011839383
Symbol
DRTS

Alpha Tau Medical Stock price

$13.72
-0.76 5.25% 1M
+6.13 80.76% 6M
+8.77 177.17% YTD
+9.92 260.67% 1Y
+10.55 332.81% 3Y
+3.80 38.31% 5Y
+3.62 35.84% 10Y
+3.62 35.84% 20Y
Nasdaq, Closing price Fri, Nov 06 2026
+0.42 3.16%
ISIN
IL0011839383
Symbol
DRTS

Is Alpha Tau Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$1.2b
Net debt
positive
Cash
$76.4m
Shares outstanding
90.2m
Valuation
P/E
negative
P/S | estimate
- | 990.7
EV/Sales | estimate
- | 933.8
EV/FCF | ex SBC
negative | negative
P/B
17.6
Financial Health
Equity Ratio
73.0%
Return on Equity
-55.3%
ROCE
-47.1%
ROIC
-
Debt/Equity
0.1
Financials
Revenue | estimate
$0.0 | $1.2m
EBITDA
-
EBIT
$-46.3m
Net Income
$-56.9m
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
- | -
EBITDA
-
EBIT
-25.4%
Net Income
-75.2%
Free Cash Flow
-
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$-0.6
FCF per Share
-
Short interest
5.4%
Employees
121
Rev per Employee
$0.0

Alpha Tau Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Alpha Tau Medical forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Alpha Tau Medical forecast:

Buy
82%
Hold
18%

Financial data from Alpha Tau Medical

Mar '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 10 10
14% 14%
-
- Research and Development Expense 36 36
29% 29%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -46 -46
25% 25%
-
Net Profit -57 -57
75% 75%
-

In millions USD.

Don't miss a Thing! We will send you all news about Alpha Tau Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alpha Tau Medical Stock News

Neutral
GlobeNewsWire
●
11 days ago
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings TA-125 tracks the 125 largest and most prominent companies on the TASE JERUSALEM, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq and TASE: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that its ordinary s...
Neutral
GlobeNewsWire
●
18 days ago
- MOU relates to a potential clinical trial in South Korea, Alpha DaRT's first, at Samsung Medical Center (SMC) in Seoul, ranked fifth in the world and number one in Korea in oncology - - In Korea, only about one in five pancreatic cancer patients undergo surgery, and the disease's death rate rose over 6% in 2025, the steepest increase among major cancers - JERUSALEM, Oct. 22, 2026 (GLOBE NEWSW...
Neutral
GlobeNewsWire
●
21 days ago
- FDA approves IDE supplement expanding REGAIN from 10 to 20 patients, with additional study endpoints and interim analysis - - Abstract authored by REGAIN study principal investigator Dr. Joshua Palmer of The Ohio State University accepted for presentation at the Society for Neuro-Oncology (SNO) 2026 Annual Meeting, marking the trial's first appearance at a scientific meeting - - Glioblastoma ...
More Alpha Tau Medical News

Company Profile

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Head office Israel
CEO Mr. Sofer
Employees 121
Founded 2015
Website www.alphatau.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today